Healthtech & Wellness VC Funds

Diamond Capital is a venture capital firm based in Taiwan, primarily focusing on investments in the biotechnology, medical, and high-tech sectors. Established in 2013, the firm has built a strong reputation for nurturing innovative companies that are driving advancements in healthcare, new drug development, high-end medical equipment, and innovative medical services. Diamond Capital is known for its strategic investments that span early to growth-stage companies, particularly those operating in Asia. The firm is particularly noted for its involvement in the biotechnology sector, where it has been instrumental in supporting startups that have gone on to achieve significant milestones, including public listings. Diamond Capital's strategy involves not only providing capital but also leveraging its extensive network and expertise to guide companies through the complexities of scaling and entering global markets. This approach has made it a key player in Taiwan’s venture capital landscape. In 2023, Diamond Capital made headlines by becoming the first biotech venture capital firm to list on the Taiwan Stock Exchange, further enhancing its visibility and credibility on the international stage. The firm's portfolio includes a diverse array of companies, from cutting-edge biotech firms to innovative medical device manufacturers, all of which are united by their potential to make significant contributions to their respective fields.

DCP Capital is a private equity firm based in Beijing, China, founded in 2017 by Julian Wolhardt and David Liu. The firm focuses on investments in companies operating in sectors such as healthcare devices, semiconductors, commercial services, agriculture, and manufacturing across Mainland China, Hong Kong, Macau, and Taiwan. Notable investments by DCP Capital include Jamieson Wellness, a leading consumer health brand; Mengniu Dairy, one of China’s largest dairy producers; and 51job, a major recruitment website in China, which was acquired for $3.8 billion. The firm has also invested in innovative companies like Broncus Medical, Venus MedTech, and Fenbi, which focuses on education and training services. DCP Capital manages assets of over $2.5 billion, having recently completed the first close of their second China fund. This fund aims to invest in early and growth-stage companies, furthering their mission to support transformative businesses in the region.

Digital Leaders Ventures (DLV) is a European venture capital fund founded in 2014 and headquartered in Luxembourg, operating as a fully registered alternative investment fund manager and AIF. The firm was founded by Monty C. M. Metzger, a serial entrepreneur and digital futurist, and Thomas S. Enge, a financial executive and former CFO at simyo and amaysim. DLV invests through its Ignition Fund in fast-growth tech companies with scalable business models, targeting startups that have working products, early customers, and initial revenues — typically post-accelerator or post-seed stage. With 8 investments to date, DLV writes checks of $100,000 to $1 million at Seed and Series A. The fund focuses on six key sectors: Smart Cities, Education, Healthcare, Finance including blockchain, Communication, and Mobility and Industry 4.0. Portfolio companies include Aircall (cloud-based phone systems), PayKey (mobile banking via social keyboards), Cortrium (cardiac monitoring), Revue (newsletter platform acquired by Twitter), and VOIQ. Co-investors have included Balderton Capital, Greylock Partners, Y Combinator, and 500 Startups. DLV leverages its global network through DigitalLeaders.co to support founders scaling internationally, with portfolio companies headquartered across the USA, Israel, Denmark, France, and the UK. The firm also maintains a syndicate on AngelList, broadening its deal access and co-investment capacity across the European and global tech landscape.

Digital Ventures LatAm is a Santiago-based venture capital firm that emerged from the Digital Bank LATAM ecosystem, founded by Ramon Heredia. The firm invests in early-stage B2B digital solutions across Latin America, with a strong emphasis on startups serving the financial industry. Focus sectors include fintech, AI, health tech, blockchain, and SaaS, with check sizes from $250,000 to $5 million at pre-seed and seed stages. The firm leads rounds in its portfolio companies. Digital Bank LATAM, the parent ecosystem from which the firm grew, was founded in 2013 and operates across Chile, Peru, and Colombia as an innovation platform for digital banking. Ramon Heredia brings more than 30 years of experience in Latin American financial services, has founded or co-founded seven companies, authored four books on fintech and digital transformation, and created the Espacios Vacíos innovation methodology. The firm set an early ambition to build a portfolio of at least 100 startups to accelerate digital transformation across the region. Digital Ventures LatAm functions as both an investor and an accelerator, providing strategic support and leveraging extensive financial industry networks to connect portfolio companies with banks, insurers, and digital lenders across Chile and broader Latin America. Its position at the intersection of traditional financial services and emerging technology gives it a distinctive sourcing and value-creation edge in a region where fintech adoption is expanding rapidly.

DigitalDx Ventures is a majority women-owned, early-stage venture capital fund founded in 2018 and headquartered in Menlo Park, California. Founded and led by Michele Colucci, the firm invests in health technology companies that use artificial intelligence and big data to transform diagnostics and therapeutics. Target areas include breast and other cancers, cardiovascular and kidney health, Alzheimer's disease, and mental health diagnostics. The fund has raised two funds with combined AUM under $25 million. With 8 investments to date, DigitalDx leads rounds at pre-seed through Series A stages with average checks of approximately $1.5 million. Portfolio companies include NOWDiagnostics (for which the firm led a $22.5 million Series B), Oxford Cancer Analytics, and GLX Analytix. Over 50% of portfolio companies feature women founders or C-suite executives. The investment team — including partners Eric Weiss, Vanessa Small, Melody Po, Sharad Mishra, and Erin Niehaus — applies a proprietary evaluation model called iTED (Investment Tool for Expert Diagnostics) that weighs team diversity, problem scale, and solution invasiveness. DigitalDx maintains a robust Experts and Entrepreneurs in Residence program with 24-plus distinguished operators from medicine, engineering, finance, law, and pharma, alongside a fellowship program that has enrolled more than 100 participants from top global universities. The firm's scientific advisory board includes Nobel Prize-winning scientists and Fortune 100 executives, giving portfolio companies access to clinical and commercial validation well beyond what the fund size alone would suggest.

Digitalis Ventures is a venture capital firm established in 2016, focused on investing in innovative solutions within the realms of human and animal health. Headquartered in New York, with offices in Boston, Los Angeles, San Diego, San Francisco, and Gainesville, the firm leverages deep technical, financial, and domain expertise to support early-stage companies. Digitalis Ventures’ portfolio includes companies like Expressable, Elegen, and Alterome Therapeutics, reflecting their interest in biotechnology, health technologies, and services. Notable exits include Scout Bio and PetMedix. The firm typically leads investment rounds, providing substantial capital and strategic guidance to help startups scale. The investment strategy centers around life sciences, health technologies, and animal health. They invest in companies developing breakthrough technologies in therapeutics, diagnostics, and tools that improve healthcare access, outcomes, and efficiency. Their Companion Fund specifically focuses on advancing animal health. Key team members include founder Geoffrey Smith and partners such as Amit Bansal and Drew Taylor, who bring extensive experience in venture investing and health technologies.

firm focuses on investing in early-stage companies within the digital health sector, aiming to address significant challenges and inefficiencies in healthcare. Their investment strategy centers on data-driven technologies that can revolutionize healthcare and improve patient outcomes through innovative solutions in personalized medicine, data analytics, and digital therapeutics. DigiTx Partners is notable for backing companies like Eko, which develops diagnostic devices for heart and lung diseases, and Rune Labs, which focuses on precision neurology through software and data analytics. Their portfolio also includes Cleerly, specializing in cardiovascular disease diagnostics, and Savonix, which offers cognitive function management systems. The firm was created as a joint venture between Astellas Pharma and MPM Capital, and it raised $75 million for its Rx Digital Fund in 2018. This fund supports seed and Series A-stage companies that are developing healthcare and life sciences technology utilizing data​. Key team members include Managing Director David Kim, MD, and Partner & Principal Miraj Sanghvi, who bring substantial expertise in healthcare and investment management.

Dimension Capital is an early-stage venture capital firm founded in 2022 by industry veterans from Lux Capital and Obvious Ventures. With a focus on the intersection of biotechnology, life sciences, and technology, the firm operates a $350 million fund aimed at digitizing the biotech sector. Their mission is to break down the traditional silos separating technology and life sciences, creating new synergies between fields like drug discovery and artificial intelligence. Dimension invests in startups that leverage technology to drive advancements in biotech, such as Enveda Biosciences and Kaleidoscope Bio. The firm targets transformative companies in sectors including AI-driven drug discovery, machine learning applications in healthcare, and advanced manufacturing. Led by Adam Goulburn, Zavain Dar, and Nan Li, Dimension emphasizes long-term partnerships with founders, providing both capital and strategic guidance. They are particularly interested in companies at the forefront of merging biology with computational technologies, a space they believe is critical to the future of medicine​. Based in New York and San Francisco, Dimension is well-positioned in two key innovation hubs, giving it access to cutting-edge talent and startups that are redefining the biotech landscape​.

Disruption Ventures is a private, female-founded venture capital firm based in Toronto, Canada, founded in 2018 by Elaine Kunda. The firm invests exclusively in companies founded and led by women, targeting North American high-growth startups at the Seed stage with a target fund size of $30 million. Scotiabank is a notable LP, and the firm is a member of Beyond The Billion, a global consortium channeling capital to women-led funds. The team includes General Partner Elaine Kunda, Partner Eugene Bomba (a CPA with CFO experience at ThoughtWire), and Principal Sarah Shapiro. Disruption Ventures leads rounds and writes checks averaging $750,000, investing across B2B SaaS, health tech, e-commerce, edtech, fintech, and AI. The portfolio spans eight investments in two funds. Fund I companies include PracticeBetter (health and wellness practice management SaaS), Hostfully (vacation rental property management), MakerKids (coding and robotics education), Fable (digital accessibility testing, exited), and ePACT (emergency management SaaS, exited November 2022). Fund II investments include Blanka (beauty e-commerce drop-shipping), Ginger Desk (virtual medical office assistants), and Vee (AI platform for nonprofits). The firm emphasizes operational support alongside capital, applying data-driven metrics analysis and a strong advisor network to help portfolio companies scale. By focusing exclusively on women founders, Disruption Ventures addresses a persistent gap in the Canadian venture market, where female-led startups have historically received a disproportionately small share of venture investment.

Digital Horizon is a forward-thinking venture capital firm that backs entrepreneurs at every stage of their journey, focusing on fintech, SaaS, and AI startups. They have a notable portfolio including Klarna, Lemonade, Monday.com, Ably, and Bolt, showcasing their knack for identifying high-potential ventures. Founded by Alan Vaksman, Digital Horizon leverages a global network with a presence in London, Tel Aviv, and Dubai, emphasizing support for immigrant founders and diverse teams. Their investment strategy is unique, employing a multi-stage approach that spans from early-stage to later-stage investments, ensuring high returns and liquidity. This method has proven successful, with their first fund achieving an impressive 40% annual return. They prioritize startups solving real-world problems with a clear path to profitability, even if immediate profitability isn’t required. Digital Horizon is actively expanding into the Middle East, with a focus on Dubai and the broader MENA region. They target sectors like e-commerce, digital payments, crypto infrastructure, and B2B solutions. Founders looking for investment should be prepared to demonstrate strong problem-solving capabilities and a solid economic model. Key team members include Helena Haykin, Rohit Mathur, Vlad Tropko, and Levy Raiz, who bring extensive experience from major corporations and startups globally. For entrepreneurs seeking to connect, Digital Horizon values clear, impactful pitches that align with their mission to foster innovation and scalable growth.

Distributed Ventures is a venture capital firm that focuses on investing in startups transforming the future of risk management across sectors like Insurtech, Fintech, and Health & Benefits. Originally incubated within NFP Ventures, the firm spun out as an independent entity in 2021 to focus on supporting early-stage companies. Distributed Ventures typically invests in late seed and Series A rounds, with a strong emphasis on businesses that drive innovation in their respective fields. The firm’s investment approach is rooted in its deep industry expertise, combining financial backing with strategic guidance to help portfolio companies scale efficiently. Distributed Ventures is particularly known for its hands-on involvement, offering operational support through its team of experienced investors and operators. The firm’s portfolio includes a diverse array of startups, such as those improving healthcare delivery, enhancing financial services, and innovating within the insurance industry. This focus on sectors at the intersection of technology and risk management reflects Distributed Ventures' commitment to shaping the future of these critical industries. The firm is led by a seasoned team, including Managing Partner Shawn Ellis, who has a strong background in venture capital and corporate innovation. Distributed Ventures is also notable for its strategic partnerships, which enable the firm to provide more than just capital to its portfolio companies, helping them navigate complex regulatory landscapes and scale their operations effectively​.

District Ventures Capital is a Calgary-based venture capital fund founded in 2016 by Arlene Dickinson, the renowned Canadian entrepreneur and long-time Dragons' Den star. The firm specializes in consumer packaged goods (CPG) companies in food and beverage and health and wellness sectors across Canada and the US. Fund I closed at $100 million in September 2019 with institutional LPs including OMERS ($33 million), BMO, Farm Credit Canada, and BDC Capital. Fund II has followed with Export Development Canada (EDC) as a committing LP. With 48 investments to date, District leads rounds with typical checks in the $500,000 to $5 million range. Portfolio companies include Just Vertical (hydroponic growing systems), Three Farmers (roasted bean snacks), and Vertiball (muscular care device). The firm's largest investment to date is a $20 million deal in Huha Wear Inc. (women's intimate apparel), co-invested with EDC in November 2025 — the largest investment in Dragons' Den's 20-year history, originating from Season 18. Partner and CFO Jason Berenstein oversees transaction origination, due diligence, and fund operations. District also operates Venturepark Labs, an accelerator program investing $150,000 per startup in semi-annual cohorts, giving the firm a built-in pipeline of early-stage consumer brands. The combination of Dickinson's public profile, institutional LP base, and operating accelerator makes District well-positioned to identify and accelerate emerging CPG brands before they reach broad retail distribution.

Divergent Capital is a New York-based venture capital firm founded in 2020 by Katie Shea and Lucy Wang. The fund focuses on pre-seed investments, typically writing checks between $250,000 and $750,000. Divergent Capital aims to back 20-25 companies, emphasizing high-conviction investments with deep engagement in sectors like AI, machine learning, robotics, biotech, logistics, and digital health. The firm is known for investing in founders with innovative technologies and unique customer insights, often those outside the traditional Silicon Valley circles. Divergent takes a hands-on approach with its portfolio companies, offering strategic guidance on product development, go-to-market strategies, and scaling. They prefer working with founders who have a deep personal connection to the problem they are solving, focusing on practical, product-driven growth rather than market size alone. Notable investments include companies like Hoop, Motif Neurotech, and Ceragen, spanning industries from productivity software to biotechnology.

dmg ventures is the corporate venture capital arm of Daily Mail and General Trust plc (DMGT), launched in 2018 and headquartered in London. The firm leverages DMGT's media properties — including the Daily Mail, MailOnline, The Metro, and The i newspaper — reaching more than 155 million global monthly consumers to help portfolio companies achieve consumer scale. The team of seven is led by CEO and Co-Founder Manuel Lopo de Carvalho, alongside partners Rachel Muzyczka and Taos Edmondson. The firm operates two funds totaling £50 million: the Headline Fund (£25 million) investing £250,000 to £1.5 million at Seed to Series A, and the Scale Fund (£25 million) providing £1 million to £5 million primarily through media-for-equity deals at Series B and beyond. The portfolio of 34 companies includes one unicorn (Zilch, a BNPL fintech), two IPOs (Taboola on NASDAQ, Cazoo on NYSE), and six acquisitions including Farewill (acquired by Dignity). Additional investments include Impossible Foods, Lucky Energy, and Final Boss Sour. The firm's distinctive model blends cash investment with discounted media credits, giving portfolio companies guaranteed sponsored content opportunities across DMGT's publications. This combination of capital and commercial media reach is particularly effective for consumer, retail, fintech, and food and beverage brands that need to build mass awareness cost-efficiently. Geographic focus spans the UK, US, and Western Europe.

DN Capital, founded in 2000, is a global early-stage venture capital firm with offices in London, Berlin, and San Francisco. They focus on Seed, Series A, and select Series B opportunities across Europe and North America. The firm specializes in sectors such as fintech, SaaS, digital media, marketplaces, and consumer internet. Some of DN Capital's notable investments include Shazam, Auto1, OLX, Purplebricks, and GoStudent. These investments showcase DN Capital's knack for identifying and supporting companies that can scale globally. They have managed over $1 billion in assets and achieved numerous successful exits, including acquisitions by major corporations such as Apple (Shazam) and Oracle (Endeca)​. The firm is led by founders Nenad Marovac and Steve Schlenker, who bring deep entrepreneurial and financial expertise. DN Capital emphasizes a hands-on approach, providing portfolio companies with strategic guidance, business development opportunities, and extensive network connections. Their commitment to openness and integrity, combined with rigorous investment practices, makes them a strong partner for ambitious entrepreneurs

DNS Capital is the investment office for Gigi Pritzker and her husband Michael Pucker, based in Chicago. Founded in 2014, DNS Capital invests across various stages and industries, emphasizing long-term partnerships and strategic growth. The firm has a diverse portfolio with significant investments in technology, healthcare, and industrial sectors. Notable investments include Hero Bread, which focuses on producing low-carb bakery products; IMIDomics, a biotech company working on therapeutics for immune-mediated inflammatory diseases; and Jetti Resources, which has developed a novel technology for metal extraction from ores. Other key investments include Recogni, a company specializing in high-performance computer chips for autonomous vehicles, and PayNearMe, a platform enhancing payment experiences for businesses and their customers​​. DNS Capital's approach combines financial support with strategic guidance, leveraging the deep expertise of its leadership team. They focus on building strong relationships with business owners and management teams to drive sustainable growth and innovation across their portfolio companies​.

DNV (formerly DNV GL) is a global leader in quality assurance and risk management, with roots tracing back to 1864. Headquartered in Norway, the company provides a wide range of services across various industries, including maritime, oil and gas, renewable energy, and healthcare. DNV focuses on enhancing safety, efficiency, and sustainability through its services, which include classification, technical assurance, certification, and advisory. In 2021, DNV rebranded from DNV GL, reflecting its streamlined strategy for the future. The company is organized into six main business areas: Maritime, Energy Systems, Business Assurance, Supply Chain & Product Assurance, Digital Solutions, and the Accelerator, which fosters growth through acquisitions and partnerships. DNV invests heavily in research and development, dedicating about 5% of its annual revenue to innovation. This commitment is evident in its work on projects related to the energy transition, digital assurance, and artificial intelligence, aiming to set new global standards in these areas. The company’s recent acquisitions, such as Nixu, a cybersecurity firm, and ANB Systems, a SaaS provider for energy programs, highlight DNV’s strategic expansion into critical sectors like cybersecurity and digital transformation. DNV is owned by Stiftelsen Det Norske Veritas, a foundation with the mission of safeguarding life, property, and the environment. This ownership structure supports DNV’s long-term vision and commitment to sustainability, as all profits are reinvested into the company to further its mission​.

DNX Ventures is an early-stage venture capital firm specializing in B2B startups, with a particular focus on SaaS, cybersecurity, fintech, deep tech, sustainability, and retail tech sectors. Founded in 2011, DNX Ventures operates from offices in Silicon Valley and Tokyo, bridging two of the world's most innovative markets. The firm invests in seed and Series A startups, typically providing initial investments ranging from $1 to $5 million. DNX Ventures aims to support founders who are tackling significant challenges for enterprise companies, helping them shape industries and transform the way we live and work. Notable investments by DNX Ventures include Cylance, ICEYE, Movandi, and Nauto. Their approach emphasizes close partnership with portfolio companies, offering extensive support and resources to help them succeed.

Dolby Family Ventures is a San Francisco-based venture capital firm founded in 2014 by David Dolby, investing in early-stage companies tackling frontier science and engineering challenges. Unaffiliated with Dolby Laboratories, the firm manages approximately $196 million in assets under management. The 16-person team is led by David Dolby as CEO, Senior Managing Director Pascal Levensohn, and Managing Director Andrew Krowne, supported by a distinguished Scientific Advisory Board. With 106 investments and a strong exit track record of 6 IPOs and 17 acquisitions, Dolby Family Ventures leads rounds across pre-seed, seed, and Series A with checks from $1 million to $25 million. The five core verticals are precision neuroscience (neurodegeneration, psychiatry, neurotech), life sciences platforms (regenerative medicine, computational biology), climate tech, aerospace, and digital deep tech. Portfolio companies include Motif Neurotech, Therini Bio, Ursa Major Technologies, Twelve, Paradromics, Bionaut Labs, and DigiLens. IPO exits include Athira Pharma, Eargo, Cognition Therapeutics, and Tempo Automation; acquisition exits include August (by Assa Abloy), Wickr (by Amazon), and Eyefluence (by Google). The firm takes a long-term collaborative approach, partnering with best-in-class innovators and syndicate partners to build transformative technology companies. Its willingness to back science-forward ventures at the earliest stages — often where commercial validation is years away — and the depth of the Scientific Advisory Board distinguish DFV from generalist firms operating across the same broad technology sectors.

Domain Capital Group, founded in 1985, specializes in biotechnology investments, managing a substantial $2.8 billion in assets. They have funded 194 companies in the biopharma, medical device, and diagnostic sectors, resulting in 90 IPOs and 110 M&A events. Notable companies in their portfolio include Zipline, GitLab, and DigitalOcean. Domain Capital’s strategy focuses on long-term partnerships and a diversified asset approach, investing in real estate, natural resources, media, entertainment, technology, and special situations to achieve stable, cash-on-cash returns. They operate globally with a team led by seasoned partners like James Blair and Brian Halak. Their investment process involves rigorous due diligence, strategic transaction structuring, and active asset management to ensure value creation and capital preservation. Domain Capital typically engages in growth and late-stage investments, leveraging their extensive industry experience and strong relationships to source and manage deals effectively. The firm’s hands-on approach includes personalized investor engagement, aiming to meet specific investment goals such as targeted returns and risk mitigation. This comprehensive strategy positions Domain Capital as a trusted partner for public and private pension plans, corporations, foundations, endowments, and high-net-worth individuals.

Dorm Room Fund (DRF), founded in 2012 by Josh Kopelman under the auspices of First Round Capital, is a venture capital firm that focuses on investing in student-run startups. Headquartered in Cambridge, Massachusetts, DRF has made over 400 investments and has achieved 145 exits. Notable exits include MetaMap, DiscreetAI, WorkerSense, and ScienceIO. DRF’s mission is to support student founders by providing access to a powerful investor network, world-class mentors, and essential capital to accelerate their growth. The fund has supported over 300 companies led by student founders, including prominent names like Athelas and WellTheory. Dorm Room Fund is dedicated to promoting diversity, equity, and inclusion within the venture capital industry. Nearly 80% of their alumni go on to become founders or venture capitalists themselves. The fund has created initiatives like the Blueprint Project and the Female Founder Track to empower underrepresented students. The investment team at DRF consists of student partners who bring unique insights into the next wave of groundbreaking companies. This model allows them to identify promising startups that might be overlooked by traditional investors.

Dow Venture Capital, a corporate venture arm of Dow Inc., focuses on strategic investments that align with Dow's broader goals of sustainability and innovation. Established in 1994, the unit is headquartered in Midland, Michigan, and targets a range of sectors including clean technology, advanced materials, recycling, and healthcare. Their investments often seek to advance circular economy solutions, such as their partnerships with companies like Plastogaz, which aims to simplify plastic recycling processes through advanced catalytic technology, and Mura Technology, which focuses on chemical recycling for hard-to-recycle plastics. Dow Venture Capital also collaborates with companies in the fields of renewable energy, water treatment, and sustainable agriculture, demonstrating their commitment to tackling global environmental challenges. With a presence across North America, Europe, and Asia, their approach blends Dow’s extensive materials science expertise with innovative startup technologies, facilitating solutions that can scale globally. Dow's focus on recycling has led to investments that aim to close the loop on plastic waste, ensuring materials can be reused sustainably​. Overall, Dow Venture Capital plays a key role in Dow’s strategic direction by supporting startups that drive growth and value, particularly in areas that complement their sustainability mission and core business sectors.

Downing LLP is a UK-based investment management firm that emphasizes sustainable and impactful investments across various sectors. Established in 1986, Downing manages around £2 billion in assets, offering a diverse range of investment strategies. It has built a reputation for responsible investing, holding a B Corp certification, which underscores its commitment to balancing profit with social and environmental responsibility. Downing Ventures, a division of Downing LLP, focuses on early to growth-stage technology companies. Their investment portfolio spans sectors including healthcare, clean technology, and software, with a preference for businesses that integrate sustainability and innovative solutions. Recent initiatives include the appointment of Dr. Nigel Pitchford as Head of Healthcare Ventures, reflecting their strategic focus on med-tech and life sciences. This division has supported over 20 healthcare companies, deploying more than £36 million since 2014. In addition to venture capital, Downing also invests in renewable energy projects, infrastructure, and property finance. They operate the Downing Renewables & Infrastructure Trust (DORE), which funds solar, wind, and energy storage projects across the UK and Northern Europe. Through these ventures, Downing aims to deliver stable returns while promoting environmental sustainability​.

DRADS Capital is a Boston-based venture capital firm focused on investing in groundbreaking innovations within the life sciences, biotechnology, and artificial intelligence sectors. The firm is driven by a mission to back visionary entrepreneurs who are pushing the boundaries of science and technology to create a healthier future. DRADS Capital targets early to late-stage companies that offer transformative solutions to some of the world's most challenging health problems. Founded by A. Nagarajan Pillay, a seasoned entrepreneur with over 25 years of experience, DRADS Capital has built a diverse portfolio that includes companies specializing in areas such as organ regeneration, precision fermentation, and AI-driven healthcare solutions. The firm is known for its hands-on approach, working closely with startups to navigate the complexities of bringing innovative healthcare products to market. DRADS Capital operates with a small, tight-knit team of experts who are deeply involved in every aspect of the investment process. This team includes professionals with backgrounds in law, venture capital, and global business development, all contributing to the firm's strategic vision.

Draft Ventures (Draft VC) is a venture capital firm dedicated to supporting early-stage startups that are shaping the future across a range of industries. With a mission to empower entrepreneurs, Draft VC focuses on identifying high-potential companies and providing them with the capital, mentorship, and resources needed to accelerate their growth. The firm takes a founder-first approach, partnering with innovative teams that are disrupting traditional markets and creating new opportunities in areas such as technology, healthcare, consumer products, and more. Draft VC stands out for its commitment to a collaborative investment process. The firm works closely with its portfolio companies, offering more than just financial support. Founders gain access to a vast network of industry experts, experienced operators, and fellow entrepreneurs, which helps them navigate the complexities of scaling a business. By taking an active role in the development of its investments, Draft VC ensures that founders are equipped with the tools they need to achieve long-term success. The firm is particularly interested in startups that leverage cutting-edge technology and innovative business models to address pressing global challenges. Whether it’s advancing digital health, building new financial platforms, or creating solutions for a more sustainable future, Draft VC seeks out companies that have the potential to make a lasting impact. With a strong focus on partnership, innovation, and growth, Draft Ventures plays a pivotal role in shaping the next generation of industry leaders, helping founders bring their visions to life while delivering strong returns for investors.

Dragoneer Investment Group is a prominent San Francisco-based investment firm that focuses on long-term investments in high-growth companies. Since its founding in 2012, Dragoneer has built a reputation for partnering with dynamic businesses that are leaders in their respective industries, ranging from technology and software to consumer goods, healthcare, and financial services. The firm is known for its patient, research-driven approach to investing, aiming to foster sustainable growth for both startups and more established companies. One of Dragoneer’s core strengths is its ability to identify and invest in companies that are poised for long-term success. The firm often participates in both private and public markets, offering a flexible capital base to support companies at different stages of their growth journey. Dragoneer’s portfolio includes some of the world’s most well-known technology and consumer brands, reflecting its keen ability to back industry leaders that define innovation and scale. In addition to providing capital, Dragoneer actively works with management teams to help them achieve their strategic goals. The firm brings deep industry knowledge and access to a global network of resources, allowing portfolio companies to accelerate growth and expand their market presence. Dragoneer is committed to building strong, collaborative partnerships with founders and executives. Its focus on long-term value creation, combined with an emphasis on innovation, has made it a trusted partner for some of the most influential companies in the world. By investing in tomorrow’s leaders, Dragoneer continues to play a pivotal role in shaping the future of industries worldwide.

Draper Associates, founded in 1985 by Tim Draper, is a renowned early-stage venture capital firm based in Silicon Valley. The firm has made significant investments in transformative companies across various sectors, including technology, consumer services, and financial services. Draper Associates is known for its notable investments in companies like Hotmail, Skype, Tesla, SpaceX, Twitch, Robinhood, Coinbase, and Baidu. The firm focuses on backing innovative startups with the potential for extraordinary outcomes, often investing at the seed stage and supporting companies through their growth journeys. Draper Associates prides itself on being entrepreneur-friendly, providing extensive support and resources to help founders succeed. Draper Associates is part of the larger Draper Ecosystem, which includes Draper University, Draper Venture Network, and Draper Startup House, among other initiatives aimed at fostering entrepreneurial growth and innovation globally. The firm's investment philosophy emphasizes a global perspective, investing in industry-transforming companies across the world while maintaining a strong presence in Silicon Valley. Draper Associates continues to innovate and drive significant impact in the venture capital landscape by backing visionary entrepreneurs and leveraging its extensive network and resources.

Draper B1, founded in 2010 and headquartered in Valencia, Spain, is a venture capital firm focusing on seed and early-stage investments. They emphasize supporting ambitious founders aiming to create impactful businesses. Draper B1 has a diverse portfolio spanning B2B, B2C, software, marketplaces, artificial intelligence, blockchain, and mobile applications. Notable investments include companies like Signaturit, Streamloots, and Erudit AI. They have supported over 150 companies, providing more than just capital. Draper B1 prides itself on hands-on investment and active portfolio management, leveraging a global network to help startups scale internationally. They have had multiple successful exits, including companies such as Jeff and Civitfun. Their team, led by Managing Partners like Luz Adell and Enrique Penichet Garcia, focuses on local sourcing for global scaling, helping startups navigate both local and international markets effectively. Draper B1 is part of the Draper Venture Network, enhancing their ability to support their portfolio companies with a broad range of resources and connections.

Draper Dragon is a venture capital firm that specializes in investing in early-stage startups with a focus on technological innovation and cross-border opportunities between the U.S. and Asia, particularly China. As part of the larger Draper Venture Network, Draper Dragon leverages its global presence and network to help entrepreneurs scale their businesses and expand into international markets. The firm primarily invests in cutting-edge industries such as blockchain, artificial intelligence (AI), fintech, healthcare, and enterprise software. Founded in 2006, Draper Dragon stands out for its ability to bridge the gap between Silicon Valley and Asia’s rapidly growing tech ecosystems. The firm provides more than just capital; it offers strategic guidance, access to key markets, and connections to a wide network of industry leaders, partners, and potential customers. Draper Dragon's portfolio companies benefit from the firm’s deep expertise in both venture investing and cross-border expansion, enabling them to scale quickly and efficiently in multiple regions. Draper Dragon focuses on disruptive technologies that have the potential to create significant market shifts and drive innovation on a global scale. By identifying and backing visionary entrepreneurs, the firm seeks to foster long-term growth and success in its investments. Its proactive approach, combined with a strong emphasis on fostering partnerships between the East and the West, makes Draper Dragon a crucial player in the venture capital landscape. With a track record of successful investments and a commitment to helping startups thrive globally, Draper Dragon continues to be a trusted partner for entrepreneurs seeking to build industry-leading companies.

Drashta Ventures (now operating as Drashta Impact) is a London-based impact venture capital firm founded in 2016 by Milti Chryssavgis. The firm focuses on accelerating climate solutions and de-risking impact investing, with a mandate spanning cleantech, biotech, therapeutics, and healthcare at early and mid-stage. Chryssavgis began his career in investment management developing multi-manager portfolios of systematic trading strategies. He was later joined by Nicholas Parker — a pioneer in sustainability investing credited with coining the term CleanTech — who brings more than three decades at the forefront of impact investing. Drashta has made 4 investments to date, writing checks between $500,000 and $3 million at Seed and Series A stages. Portfolio companies include Solarvest BioEnergy, which received $1 million in initial financing plus a $750,000 second tranche from the firm. Ecosystem partners include Jaderberg & Cie (impact family office), Greenbackers (climate and cleantech specialists), and Innovator Capital (London-based climate tech advisory). The firm's defining structural innovation is a capital preservation model under which Drashta only profits when underlying investments succeed and after investors receive their initial outlay and returns in full. This structure, combined with the firm's Ecosystem Investing approach, is designed to reduce barriers to deploying capital into climate solutions. The team spans 9 nationalities, speaks 11 languages, and draws on backgrounds in private equity, cleantech, investment banking, international development, and insurance.

Dreamcraft Ventures, founded in 2019 and based in Copenhagen, Denmark, is an early-stage venture capital firm focused on investing in tech-driven startups across the Nordics and Europe. With a strong emphasis on industries like gaming, esports, B2B SaaS, digital entertainment, and fintech, Dreamcraft has developed a hands-on approach to supporting founders from seed to Series A. The firm refers to itself as "venture engineers," offering operational support and strategic guidance to help companies scale. Dreamcraft has a strong generalist investment strategy, reflected in its diverse portfolio that includes companies like Hiber, a social entertainment platform, and GRID, which leverages esports data assets. The firm raised €66 million for its second fund, Dreamcraft Fund II, and continues to actively invest in early-stage companies with a focus on helping them grow into category leaders. Founded by Jesper Søgaard and Christian Kirk Rasmussen, who built Better Collective into a billion-dollar company, Dreamcraft brings founder experience to the table, focusing on high-quality teams and long-term partnerships.

Dreamers VC, founded by Will Smith and Keisuke Honda, is a venture capital firm based in Los Angeles, focusing on early-stage investments across various sectors including health biotech, finance tech, consumer products, and entertainment. Since its inception, Dreamers VC has built a diverse portfolio of innovative companies. Their notable investments include Beam Therapeutics, which is pioneering precision genetic medicines; Nurx, providing personalized healthcare solutions delivered directly to consumers; and Sandbox VR, offering immersive group virtual reality experiences. Other significant investments include HomeCourt, a basketball training app, and Public, a platform for investing in crypto assets. Dreamers VC emphasizes community and leveraging their global network to connect founders with valuable resources. Their approach combines financial support with strategic guidance, ensuring startups have the tools they need to grow and succeed in competitive markets.

Dreamit Ventures is a leading venture capital firm that focuses on early-stage investments in Healthtech and Securetech startups. Founded in 2008, Dreamit has invested in over 350 companies, helping them scale revenues and achieve significant growth. Notable investments include SeatGeek, Redox, Eko, and Trendkite. Dreamit typically invests in companies that already have revenue or pilots, focusing on those ready to scale rapidly. The firm provides substantial support through its Customer Sprints® and Investor Sprints®, connecting founders with potential customers and investors. This approach helps startups gain traction and secure additional funding. Dreamit’s portfolio companies benefit from deep vertical expertise in cybersecurity, healthcare, and digital health, among other sectors. The firm is headquartered in New York and has a strong presence in the venture capital ecosystem, with a wide network of partners and advisors. Dreamit's investments are characterized by a focus on transformative technology and innovative solutions that address critical needs in their respective industries. For startups looking to engage with Dreamit, it is essential to demonstrate a clear path to revenue growth and scalability. The firm values strong, actionable business plans and provides ongoing support to help companies navigate the challenges of early-stage growth.

Dreampact Ventures is a venture capital firm founded in 2018 and headquartered in New York City, with additional offices in Miami and St. Louis. The firm was founded by six former Anheuser-Busch InBev (AB InBev) executives — Luiz Edmond, Pablo Gonzalez, Joao Guerra, Gustavo Pimenta, Odilon Queiroz, and Fued Sadala — bringing complementary backgrounds spanning strategy, sales, finance, M&A, and technology from one of the world's largest consumer goods companies. Dreampact manages approximately $10 million in AUM and invests at Seed and Series A stages in companies already generating revenue and ready to scale. The firm leads rounds, targeting five core sectors: financial technology, education technology, entertainment including gaming and esports, longevity and wellness, and connected world technologies including smart cities and autonomous vehicles. Checks range from $1 million to $5 million, typically seeking 10% equity. Portfolio companies include PhotoniCare (medical imaging for ear diagnostics), Ryvit (construction software, acquired January 2023), Misfits Gaming (esports organization), Balance The Superfood Shot (health food), and Become (fintech, formerly Lending Express). The founding partners apply the management disciplines learned at a global CPG enterprise — systematic stage-gate evaluation, cross-functional go-to-market execution, and rigorous post-investment mentorship — to early-stage startups. Their thesis is that founders benefit most from investors who have operated large organizations and understand how to build businesses beyond the initial product phase, not just provide capital.

Drive by DraftKings is a multi-stage venture capital firm that focuses on the intersection of sports, gaming, media, and human performance. Launched in 2019, the fund was founded by DraftKings in partnership with notable firms like General Catalyst, Accomplice, and Boston Seed Capital. Under the leadership of CEO Meredith McPherron, the firm has quickly become a leader in SportsTech and entertainment investments. Drive by DraftKings backs companies that push the frontier of fan engagement, human performance, and data-driven insights. They’ve invested in cutting-edge startups such as Whoop, FanPower, and Toya, positioning themselves at the core of technological transformation in the sports industry. With access to elite athletes, industry leaders, and sports organizations, they offer unique resources to their portfolio companies. The firm's investment strategy revolves around early to growth-stage companies, focusing on opportunities in esports, mobile sports betting, and AI-driven sports tech. With over $20 billion invested in their core sectors, Drive by DraftKings sees significant growth potential in the ongoing evolution of sports and media. The team includes influential figures like Kiki Mills Johnston (Partner) and advisors such as MLB executive Theo Epstein and NFL legend Larry Fitzgerald. Startups looking to partner with Drive by DraftKings benefit not only from capital but also deep industry connections and strategic insights.

Drive Capital is a prominent venture capital firm based in Columbus, Ohio, founded in 2013 by Mark Kvamme and Chris Olsen, both of whom previously worked at Sequoia Capital. The firm focuses on investing in technology startups outside of Silicon Valley, with a particular emphasis on the Midwest, aiming to prove that world-class technology companies can emerge from any region in the United States. Drive Capital has raised over $2 billion to invest in startups solving significant problems in large markets. They have backed more than 80 companies, including notable investments like Duolingo, Root Insurance, Olive, Greenlight, and ApplyBoard. The firm is stage-agnostic, investing in seed, early-stage, and later-stage companies across various sectors such as healthcare, consumer services, information technology, and life sciences. The firm operates with a strong conviction in the potential of entrepreneurs from non-traditional tech hubs and emphasizes long-term partnerships. They seek out market-defining companies and prefer to journey with their portfolio companies from inception to IPO. Drive Capital's strategy is deeply rooted in leveraging local talent and resources, ensuring startups have the best advantages by building where they are strongest. Drive Capital's team includes a diverse group of investors committed to supporting founders with honesty and strategic guidance. They maintain a robust network and offer substantial resources to help startups navigate their growth trajectories. For entrepreneurs looking to engage with Drive Capital, the firm values bold, innovative ideas that address large market opportunities and demonstrate potential for significant impact​.

Droia Ventures is a Belgium-based venture capital firm that specializes in early-stage biotech investments, focusing exclusively on oncology and genetic diseases. With over €450 million under management, Droia supports young drug development companies that leverage cutting-edge science to bring breakthrough therapies to patients. Their portfolio includes companies such as Actio Biosciences and Vicinitas Therapeutics, which are focused on drug discovery in these high-impact areas. The firm’s investment strategy is highly targeted, aiming to fill the unmet medical needs in cancer treatment and genetic diseases like cystic fibrosis and hemophilia. Droia’s funds typically invest in newly founded or early-stage platform companies, often providing both financial backing and scientific expertise to help startups develop first-in-class drug candidates. Droia’s global reach is evident in its investments across the U.S. and Europe, with check sizes typically in the seed and early venture stages. Led by experienced partners like Janwillem Naesens and industry veteran George Golumbeski, Droia emphasizes long-term partnerships and active involvement in the scientific and business growth of its portfolio companies​.

DSM Venturing, the corporate venture arm of DSM, focuses on investing in innovative startups that align with its mission of improving health, nutrition, and bioscience. Since its inception in 2001, DSM Venturing has invested in over 100 startups across these sectors. Their portfolio includes companies such as NutriLeads, which develops food ingredients with health benefits, and Deep Branch Biotechnology, which converts carbon dioxide into sustainable animal nutrition products. Geographically, DSM Venturing is particularly active in North America and Europe. They typically invest between €1 million and €20 million over the lifetime of a venture, starting with initial investments ranging from €100k to €5 million. They take minority ownership stakes and often lead investment rounds while actively participating in the board activities of their portfolio companies​. DSM Venturing's investment strategy focuses on startups that offer transformative solutions in health, nutrition, and care, as well as animal nutrition and health, and food innovation. They aim to support these companies not only with funding but also with access to DSM's extensive scientific and commercial resources, fostering innovations that have the potential to make significant societal impacts​.

DSW Ventures is a Manchester-based early-stage venture capital firm founded in 2018, operating as the trading style of DSW Angels LLP, part of DSW Capital plc. Founded by David Smith and Keith Benson — with Doug Quinn adding life sciences expertise in 2023 and Chris Yeowart joining as partner in June 2025 — the firm exists to fill the funding gap for regional UK startups outside London. The firm is backed by British Business Investments (part of the £100 million Regional Angels Programme), family offices, and a network of more than 200 high-net-worth angel investors, with the DSW team contributing 20% to each investment. DSW has facilitated £24 million in venture funding across 29 investments, writing checks of £100,000 to £3 million into SEIS/EIS-qualifying businesses from pre-revenue through early Series A. Focus sectors include software, healthtech, life sciences, deep tech, and fintech. Portfolio companies include The Insights Family (£5.6 million Series A), InvenireX (£500,000 pre-seed, later $2.63 million seed), RoxFit (£800,000 pre-seed led by DSW in May 2025), 4D Biomaterials, Aston Particle Technologies, Propello Cloud, MesenBio, and Hike SEO. Geographic focus is exclusively regional UK businesses, distinguishing DSW from London-centric funds and making it one of the most active early-stage investors in the North of England and broader UK regions. The firm operates across the country through DSW Capital's regional office network, giving it deal flow from academic spin-outs, local accelerators, and entrepreneur communities that larger funds rarely access.

Dundee Venture Capital, founded in 2010 and based in Omaha, Nebraska, focuses on early-stage investments in high-growth technology companies. The firm is known for its hands-on approach and leadership in seed rounds, frequently leading 90% of their investments. Dundee VC invests predominantly in e-commerce, fintech, and SaaS, with notable portfolio companies including Summersalt, a direct-to-consumer lifestyle brand, and Omnia Fishing, an e-commerce platform for anglers. Their recent investments include Nyla, a no-code platform for e-commerce, and Pear Commerce, which aids grocery retailers with digital marketing. Dundee Venture Capital’s strategy emphasizes funding transformative startups located outside traditional coastal hubs. They seek companies with a strong vision, early traction, and a unique edge. With a commitment to seed-stage investing, Dundee is particularly interested in businesses that have potential for significant impact and rapid growth. The firm prefers to engage with founders who have a clear and compelling vision and are tackling urgent and valuable problems. The team, led by founder Mark Hasebroock, brings deep entrepreneurial experience and a track record of success, including the sale of Hayneedle to Walmart. Startups should approach Dundee with a robust business plan that demonstrates significant potential and a differentiated market approach.

DunRobin Ventures was a Chicago-based venture capital firm founded in 2014 by Bharat Anant and Jonathan Lee, offering an angel investor community access to Midwest startup deals. The firm focused on seed-stage technology startups in the Midwest, investing in healthtech, energy and cleantech, and enterprise software. Founded by University of Illinois Urbana-Champaign alumni, the firm operated as a full-service venture platform connecting regional founders with a curated group of angel investors. The firm made 3 recorded investments: Visibly (formerly Opternative, an online vision test and telehealth platform), Xerion Advanced Battery (advanced electrode manufacturing with DirectPlate technology, a $4.03 million total raise with DunRobin participating in the April 2016 Series B), and at least one additional undisclosed company. Check sizes were approximately $100,000 to $500,000. DunRobin's SEC Exempt Reporting Adviser status was withdrawn on October 16, 2020, and the firm is permanently closed. No investments were recorded after 2016. Bharat Anant subsequently held senior finance and strategy roles at SensorTower and Constructor.io. The firm's brief operating history reflects the challenge of building a sustainable regional VC platform in the Midwest during a period when coastal venture capital dominated deal flow and LP capital allocation. It remains a documented early attempt to bring institutional-quality angel investing infrastructure to the Chicago ecosystem.

The goal of DuPont Ventures is to foster innovation by investing in early-stage startups that align with DuPont’s core areas of focus—advanced materials, biosciences, electronics, and sustainability. The venture arm helps DuPont stay on the cutting edge by engaging with innovative companies that bring disruptive technologies and solutions to market. DuPont Ventures seeks to collaborate with startups that complement its existing R&D efforts, leveraging the company’s vast resources in scientific research, engineering, and market reach. The focus is on strategic investments that can accelerate DuPont’s innovations, particularly in fields like industrial biotechnology, electronics, clean technologies, and agriculture. Startups benefit from DuPont’s global infrastructure, access to technical expertise, and opportunities to scale through DuPont’s commercial channels. The venture team looks for startups that are pushing boundaries in science and technology, providing them with both capital and strategic guidance to foster growth. In doing so, DuPont maintains a forward-looking approach, ensuring it remains competitive and continues to innovate across its key sectors. Through these strategic investments, DuPont Ventures plays a key role in expanding the company’s innovation portfolio, tapping into external talent and groundbreaking technologies that shape the future of industries.

Duro Ventures, founded in 2013 and based in San Francisco, is a venture capital firm with a broad investment portfolio that spans sectors like health, education, consumer products, and technology. The firm has a strong focus on backing mission-driven founders and companies making meaningful impacts, including in emerging areas like blockchain and VR. Some notable portfolio companies include Substack, Elroy Air, AirByte, and OpenSea, illustrating their diverse interests in consumer tech, logistics, and Web3. Duro Ventures typically invests between $10,000 and $500,000, targeting early-stage startups across industries like healthcare, commerce, and education. Their health-focused investments include Notable (personalized cancer treatment) and OssoVR (VR surgical training). Additionally, the firm has a growing emphasis on climate tech and social impact ventures. The fund is led by Edward Hu and Milan Thakor, who bring deep expertise in technology and startups. With a reputation for being founder-friendly, Duro Ventures is known for its supportive approach, often co-investing with well-known firms like Y Combinator and Gaingels. They’re actively shaping a future that balances profitability with positive global change.

Dutch Founders Fund (DFF) is an Amsterdam-based early-stage venture capital fund established by a group of successful Dutch entrepreneurs, including Laurens Groenendijk (Just Eat, Treatwell, Miinto), Patrick Kerssemakers (fonQ), Bas Beerens (WeTransfer), Hidde Hoogcarspel (Spacebuzz), and Remco van Zanten (ex-Booking.com, Zalando). The fund focuses on investing in marketplaces, network effects-driven propositions, and marketplace enablers across Europe. Notable investments by DFF include VonWood, which revolutionizes the wood industry with a transparent supply chain solution; Kennek, a SaaS-enabled marketplace for the alternative credit space; and Metycle, a global marketplace for scrap and recycled metal. Another significant investment is Mtor, an automotive parts marketplace in Egypt, addressing logistics and price transparency challenges. Additionally, HomeCooks, a foodtech platform in the UK, allows home chefs to sell their homemade dishes to a wider audience. DFF's investment strategy emphasizes providing intense mentoring from ideation to Series A, seeking companies that offer sustainable solutions and efficiency. They value founders who are ambitious, coachable, and ready to face challenges head-on. The fund is committed to simplicity, transparency, and equal distribution, ensuring every stakeholder gets a fair share of the value created. The team, with extensive experience and a strong track record in building successful companies, offers more than just capital. They dive deep into the operational aspects of their portfolio companies, providing hands-on support to help them grow and succeed.

Dux Capital is an early-stage venture capital firm founded in 2017, with a focus on supporting Latinx entrepreneurs. Based in both Austin, Texas, and Mexico City, Mexico, Dux Capital aims to bridge the funding gap for Latinx founders by investing in diverse and emerging startups that have strong growth potential and impact. The firm is led by co-founders Daniel Santamarina and José Luis Silva, who are committed to providing strategic capital and support to Hispanic-Latino entrepreneurs. Dux Capital recently achieved a significant milestone with the first close of its second fund, which attracted investments from prominent Hispanic-Latino investors and was led by Bank of America. This new fund builds on the success of their first fund and aims to continue addressing the funding disparities faced by Latinx founders. Dux Capital's investment strategy focuses on seed-stage companies across various sectors, including enterprise applications, high tech, edtech, healthtech, and fintech. Some of their notable investments include Mozper, Innovare Social Innovation Partners, and Atexto. They are known for their cross-border approach, enabling their portfolio companies to scale and succeed across different markets. The firm’s commitment to empowering Latinx entrepreneurs and its strategic partnerships underscore its role in fostering innovation and economic growth within the Latinx community.

DvH Ventures is a leading European early-stage venture capital firm based in Cologne, Germany. The firm focuses on investing in digital technology startups, with particular emphasis on sectors such as fintech, insurtech, artificial intelligence, cybersecurity, and digital health. DvH Ventures aims to support and partner with innovative companies that develop disruptive products and services. The firm operates multiple funds, including the Digital Tech Fund (DvH Ventures Fund III) and the Digital Health Fund (DvH Ventures Fund IV). The Digital Health Fund, launched in 2020 with a €70 million capital, invests across Europe in technologies that address future healthcare challenges. DvH Ventures typically invests up to €2 million in early-stage companies and often acts as the lead investor, providing follow-on capital and strategic support to its portfolio companies. DvH Ventures prides itself on being more than just a financial investor; it offers extensive operational expertise and a robust network, including media-for-equity services through partnerships with prominent media brands like Handelsblatt and DIE ZEIT. The firm is committed to fostering a collaborative and entrepreneurial environment, ensuring close and trusting interactions with founders and partners.

Dymon Asia Ventures was established in 2015 as the venture capital arm of Dymon Asia Capital, a Singapore-based alternative investment firm. In 2020, the venture arm was spun off as an independent entity and rebranded as Integra Partners, led by co-founders and managing partners Jinesh Patel and Chris Kaptein. The firm closed its second fund (Fund II) at US$90 million in 2023, bringing total AUM to over US$140 million, with LPs including DEG, US DFC, Norfund, and Tikehau Capital. Fund I delivered top-quartile returns per Cambridge Associates benchmarks and top 5% in DPI. Integra leads rounds and invests from pre-Series A to Series B with checks of US$1 million to US$5 million. The portfolio spans 38 companies with 2 IPOs and 4 acquisitions across five ESG-aligned themes: SME enablement, financial inclusion, healthcare, agri-food, and climate and environment. Portfolio companies include Brankas (open finance), Spark Systems (institutional FX), wagely (earned wage access), GIMO (earned wage access, Vietnam), graas (e-commerce aggregator), Envelop Risk (cybersecurity reinsurer), and ReaQta (cybersecurity, acquired by IBM in 2021). Jinesh Patel brings 25-plus years of Asia-Pacific investment experience across public and private markets. The team of 17-plus professionals maintains regional presence in Singapore, Philippines, India, and Pakistan. Fund III is expected with a US$150 million to $200 million target, underscoring the firm's commitment to South and Southeast Asia as a core long-term geography.

Dynamk Capital is a New York-based venture capital firm that specializes in investing in early-stage companies within the life sciences sector, particularly focusing on life science industrials. Established in 2016, Dynamk Capital targets startups that develop critical tools, technologies, and services essential for the discovery, development, and manufacturing of life-saving therapies. The firm plays a pivotal role in advancing innovative solutions across the biopharma continuum, from drug discovery to development and production. Dynamk Capital's investment strategy is centered around providing both capital and strategic support to early-stage companies, helping them scale and succeed in a highly competitive and complex industry. The firm's portfolio includes a diverse range of companies, such as RoosterBio, which specializes in cell and exosome manufacturing, and Virica Biotech, which focuses on enhancing viral vector manufacturing for gene therapy. These investments reflect Dynamk's commitment to driving innovation in biomanufacturing and life sciences. The firm recently closed its inaugural life sciences fund at $65 million, marking a significant milestone in its mission to support groundbreaking life science ventures. Dynamk Capital continues to be an active player in the venture capital space, leveraging its industry expertise to identify and nurture companies that have the potential to make substantial contributions to healthcare and biopharmaceutical advancements.

Dynamo Ventures, established in 2016 and headquartered in Chattanooga, Tennessee, is a seed-stage venture capital firm that focuses on supply chain and mobility technology. The firm is known for investing in startups that address critical issues in the logistics, transportation, and supply chain sectors. Dynamo Ventures typically invests between $250,000 and $1.2 million per seed-stage company. Their notable portfolio includes Sennder, a German digital freight brokerage that recently achieved unicorn status with a valuation of $1.45 billion. Other significant investments are STORD, a digital warehouse and distribution network based in Atlanta, and Shipamax, a digital platform for bulk shipping. Additionally, they have backed companies like Skupos, a data analytics platform for convenience stores, and Celadyne Technologies, which focuses on advanced materials for batteries. Dynamo's investment strategy is centered around providing not only capital but also extensive industry expertise and network connections to help their portfolio companies succeed. The firm recently raised $43.21 million for their second fund, more than doubling the size of their first fund, which indicates strong investor confidence in their focused approach.

e.ventures, now rebranded as Headline, is a global venture capital firm that invests across various stages and sectors, including consumer tech, SaaS, fintech, and deep tech. Originally founded as BV Capital in 1998, the firm underwent a rebranding to e.ventures in 2012 and later consolidated its identity under the name Headline in 2021. Headline operates with regional funds across the U.S., Europe, Latin America, and Asia, managed independently by local teams in cities such as San Francisco, Berlin, São Paulo, and Tokyo. This setup allows them to tap into regional expertise while maintaining a global investment strategy. Headline has raised significant funds, most recently gathering $954 million across three funds targeted at North America, Europe, and Latin America. The firm is known for its strong portfolio, which includes high-profile investments such as Bumble, Farfetch, Sonos, GoPuff, and The RealReal. These companies highlight their ability to back disruptive businesses that scale globally. Headline focuses on early to growth-stage investments, typically writing checks ranging from $1.5 million to $15 million, and uses a data-driven approach to identify promising opportunities​. With offices around the world, Headline aims to lead investment rounds and support founders by providing strategic guidance, resources, and a robust global network. Their regional expertise combined with global reach makes them a versatile partner for startups aiming to scale internationally.